Hyperlipidemia
415
23
27
297
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
72 trials with published results (17%)
Research Maturity
297 completed trials (72% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
3.6%
15 terminated out of 415 trials
95.2%
+8.7% vs benchmark
27%
113 trials in Phase 3/4
24%
72 of 297 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 297 completed trials
Clinical Trials (415)
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
Amelioration of Lipid Profile Through Date Cider-vinegar Along With 5:2 Intermittent Fasting
Effect of the β-sitosterol-enriched Dietary Plan on Lipid Levels.
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Regional Innovation in Chronic Disease and Elderly Care
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman